KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Net Income: 2018-2024

Historic Net Income for Castle Biosciences (CSTL) over the last 7 years, with Dec 2024 value amounting to $18.2 million.

  • Castle Biosciences' Net Income fell 122.08% to -$501,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.2 million, marking a year-over-year decrease of 300.86%. This contributed to the annual value of $18.2 million for FY2024, which is 131.75% up from last year.
  • Per Castle Biosciences' latest filing, its Net Income stood at $18.2 million for FY2024, which was up 131.75% from -$57.5 million recorded in FY2023.
  • In the past 5 years, Castle Biosciences' Net Income registered a high of $18.2 million during FY2024, and its lowest value of -$67.1 million during FY2022.
  • Its 3-year average for Net Income is -$35.5 million, with a median of -$57.5 million in 2023.
  • In the last 5 years, Castle Biosciences' Net Income slumped by 294.88% in 2020 and then skyrocketed by 131.75% in 2024.
  • Over the past 5 years, Castle Biosciences' Net Income (Yearly) stood at -$10.3 million in 2020, then slumped by 204.28% to -$31.3 million in 2021, then tumbled by 114.55% to -$67.1 million in 2022, then increased by 14.41% to -$57.5 million in 2023, then skyrocketed by 131.75% to $18.2 million in 2024.